The June formulary updates include the addition of 97 new National Drug Codes (NDCs), representing 63 different prescription drugs, many with multiple strengths.
The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).
Highlights of the June 2023 Formulary updates include ten (10) newly-introduced brand-name drugs
The June drug data updates include twenty-four (24) new brand-name drugs, ten (10) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
- FUROSCIX®,
- Jaypirca®,
- KITABIS PAK®,
- KONVOMEP®,
- LYTGOBI®,
- ORSERDU®,
- REZLIDHIA®,
- Subvenite®,
- TYBLUME®, and
- ZTALMY®.
The June 2023 Formulary updates include fifteen (15) newly-added generic drugs
The June Medicare Part D drug data also includes thirty-nine (39) new generic medications, fifteen (15) of which are newly-introduced generic drugs. These new generic drugs include:
- APRACLONIDINE HCL [Iopidine®],
- DILTIAZEM LA [Cardizem LA®],
- DOXYCYCLINE IR-DR [Oracea®],
- LIDOCAINE Viscous [Xylocaine Viscous®],
- LURASIDONE HCL [Latuda®],
- METHYLPHENIDATE [RELEXXII®],
- NALOCET [Primalev®],
- NEO-POLYCIN EYE OINTMENT [Polymycin®],
- NEO-POLYCIN HC EYE OINTMENT [Ocu-Cort®],
- OFLOXACIN [Ocuflox®],
- POLYCIN EYE OINTMENT [Polytracin®],
- PREDNISOLONE [Prelone®],
- CLINDACIN [Evoclin®],
- TASIMELTEON [HETLIOZ®], and
- TERIFLUNOMIDE [AUBAGIO®].
Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.
Reminders about Medicare prescription drug plan formulary changes
- Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.
- In most cases, your Medicare Part D plan
will notify you if the plan drops a medication you are currently using.
The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging. You can read more on this site
Summary of June 2023 NDC changes
There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 97 new June 2023 NDCs is as follows:
| Reason for NDC Addition | Occurrences |
| New Delivery Form | 4 |
| New Delivery Form and Strength | 6 |
| New Drug | 29 |
| New Drug and Strength | 34 |
| New Manufacturer and Strength | 4 |
| New Manufacturer, Strength and Delivery Form | 4 |
| New Strength | 16 |
| Grand Total | 97 |
The following chart details the 97 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.
You can click on the Drug Name below to go to our on this site Drug Finder ( on this site) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state). You can then change the state in our search form for details of drug coverage in your service area.
| NDC | Drug Name | Number of PDP Formularies* |
Number of MAPD Formularies* |
Notes |
| 72143025430 | ACCUTANE 40 MG CAPSULE [ZENATANE] | 52 | 355 | New Strength |
| 00121050416 | ACETAMINOP-CODEINE 120-12 MG/5 SOLUTION | 62 | 383 | New Drug |
| 52817081615 | ACETIC ACID 2% EAR SOLUTION [VoSoL] | 62 | 387 | New Drug |
| 16571088409 | ALLOPURINOL 200 MG TABLET | 0 | 6 | New Drug |
| 61314066505 | APRACLONIDINE HCL 0.5% DROPS [Iopidine] | 28 | 261 | New Drug |
| 45802081696 | CALCIPOTRIENE-BETAMETH DP OINTMENT [Taclonex] | 1 | 36 | New Drug |
| 00049271610 | CARDURA 8 MG TABLET | 1 | 2 | New Strength |
| 43538017910 | CLINDACIN 1% FOAM [Evoclin] | 4 | 32 | New Drug |
| 70436019604 | DILTIAZEM 24H ER (LA) 180 MG TABLET [Matzim LA] | 42 | 222 | New Drug and Strength |
| 70436019704 | DILTIAZEM 24H ER (LA) 240 MG TABLET [Matzim LA] | 42 | 222 | New Drug and Strength |
| 70436019804 | DILTIAZEM 24H ER (LA) 300 MG TABLET [Matzim LA] | 42 | 222 | New Drug and Strength |
| 70436019904 | DILTIAZEM 24H ER (LA) 360 MG TABLET [Matzim LA] | 42 | 222 | New Drug and Strength |
| 70436020004 | DILTIAZEM 24H ER (LA) 420 MG TABLET [Matzim LA] | 43 | 215 | New Drug and Strength |
| 70436019504 | DILTIAZEM 24H ER (LA) 120 MG TABLET [Cardizem LA] | 40 | 199 | New Drug |
| 51862056012 | DORYX MPC DR 60 MG TABLET | 0 | 3 | New Strength |
| 68308066830 | DOXYCYCLINE IR-DR 40 MG CAPSULE [Oracea] | 1 | 19 | New Strength |
| 42858086906 | DRONABINOL 10 MG CAPSULE [Marinol] | 62 | 391 | New Drug and Strength |
| 42858086706 | DRONABINOL 2.5 MG CAPSULE [Marinol] | 62 | 391 | New Drug and Strength |
| 42858086806 | DRONABINOL 5 MG CAPSULE [Marinol] | 62 | 391 | New Drug and Strength |
| 62935046150 | ELIGARD 45 MG SYRINGE KIT | 35 | 310 | New Strength |
| 60951070170 | ENDOCET 2.5-325 MG TABLET [Percocet] | 62 | 351 | New Drug |
| 59676060430 | ERLEADA 240 MG TABLET | 62 | 390 | New Strength |
| 66993008796 | FLUTICASONE-SALMETEROL 115-21 HFA AER AD [Advair HFA] | 0 | 23 | New Drug and Strength |
| 66993008896 | FLUTICASONE-SALMETEROL 230-21 HFA AER AD [Advair HFA] | 0 | 23 | New Drug and Strength |
| 66993008696 | FLUTICASONE-SALMETEROL 45-21 HFA AER AD [Advair HFA] | 0 | 23 | New Drug and Strength |
| 71767010001 | FUROSCIX 80 MG/10ML ON-BODY KIT | 1 | 47 | New Drug |
| 61314063305 | GENTAMICIN 0.3% EYE DROPS [Ocu-Mycin] | 62 | 391 | New Drug |
| 51672300701 | HYDROCORTISON-ACETIC ACID SOLUTION DROPS [VoSoL HC] | 48 | 293 | New Drug |
| 42543097025 | HYDROCORTISONE 5 MG TABLET [Cortef] | 62 | 391 | New Manufacturer and Strength |
| 00002702660 | JAYPIRCA 100 MG TABLET | 62 | 391 | New Drug and Strength |
| 00002690230 | JAYPIRCA 50 MG TABLET | 62 | 391 | New Drug and Strength |
| 24492085056 | KITABIS PAK 300 MG/5 ML AMPUL-NEB | 1 | 17 | New Drug |
| 65628027210 | KONVOMEP 2-84 MG/ML ORAL SUSPENSION | 0 | 1 | New Drug |
| 49884088099 | LAMOTRIGINE ODT KIT (BLUE) TB RD DSPK [Lamictal ODT] | 9 | 126 | New Strength |
| 49884088199 | LAMOTRIGINE ODT KIT (GREEN) TB RD DSPK [Lamictal ODT] | 9 | 124 | New Strength |
| 60432046400 | LIDOCAINE 2% VISCOUS SOLUTION [Xylocaine Viscous] | 60 | 389 | New Drug |
| 00574204230 | LIDOCAINE-PRILOCAINE CREAM (G) [SOLUPICC] | 62 | 389 | New Drug |
| 31722086525 | LINEZOLID 100 MG/5 ML ORAL SUSPENSION [Zyvox Powder] | 62 | 375 | New Manufacturer, Strength and Delivery Form |
| 16729035010 | LURASIDONE HCL 120 MG TABLET [Latuda] | 59 | 387 | New Drug and Strength |
| 16729034610 | LURASIDONE HCL 20 MG TABLET [Latuda] | 59 | 387 | New Drug and Strength |
| 16729034710 | LURASIDONE HCL 40 MG TABLET [Latuda] | 59 | 387 | New Drug and Strength |
| 16729034810 | LURASIDONE HCL 60 MG TABLET [Latuda] | 59 | 387 | New Drug and Strength |
| 16729034910 | LURASIDONE HCL 80 MG TABLET [Latuda] | 59 | 387 | New Drug and Strength |
| 64842012004 | LYTGOBI 12 MG DOSE (3X 4MG TB) TABLET | 62 | 391 | New Drug and Strength |
| 64842012005 | LYTGOBI 16 MG DOSE (4X 4MG TB) TABLET | 62 | 391 | New Drug and Strength |
| 64842012006 | LYTGOBI 20 MG DOSE (5X 4MG TB) TABLET | 62 | 391 | New Drug and Strength |
| 00078079205 | MAXITROL EYE DROPS EYE DROPPER | 0 | 2 | New Delivery Form and Strength |
| 68382054706 | MEMANTINE HCL ER 14 MG CAPSULE SPR 24 [Namenda XR] | 50 | 369 | New Strength |
| 68382054806 | MEMANTINE HCL ER 21 MG CAPSULE SPR 24 [Namenda XR] | 50 | 369 | New Strength |
| 68382054606 | MEMANTINE HCL ER 7 MG CAPSULE SPR 24 [Namenda XR] | 50 | 371 | New Strength |
| 13811071130 | METHYLPHENIDATE ER 45 MG TABLET ER 24 [RELEXXII] | 0 | 21 | New Drug and Strength |
| 13811070030 | METHYLPHENIDATE ER 63 MG TABLET ER 24 [RELEXXII] | 0 | 21 | New Drug and Strength |
| 72245019310 | NALOCET 2.5-300 MG TABLET [Primalev] | 0 | 2 | New Drug |
| 00093216568 | NALOXONE HCL 4 MG NASAL SPRAY [Narcan] | 60 | 387 | New Manufacturer, Strength and Delivery Form |
| 00574425035 | NEO-POLYCIN EYE OINTMENT [Polymycin] | 57 | 338 | New Drug |
| 00574414435 | NEO-POLYCIN HC EYE OINTMENT [Ocu-Cort] | 53 | 326 | New Drug |
| 24208043405 | OFLOXACIN 0.3% EYE DROPS [Ocuflox] | 61 | 391 | New Drug |
| 72187010203 | ORSERDU 345 MG TABLET | 62 | 390 | New Drug and Strength |
| 72187010103 | ORSERDU 86 MG TABLET | 62 | 390 | New Drug and Strength |
| 00574402135 | POLYCIN EYE OINTMENT [Polytracin] | 58 | 327 | New Drug |
| 69238145802 | POTASSIUM CL 20% (40 MEQ/15ML) LIQUID [Kaon-CL] | 59 | 386 | New Drug |
| 69238145902 | POTASSIUM CL 10% (20 MEQ/15ML) LIQUID [Kay Ciel] | 62 | 391 | New Drug |
| 00597044587 | PRADAXA 110 MG PELLET PACK | 0 | 6 | New Delivery Form |
| 00597045016 | PRADAXA 150 MG PELLET PACK | 0 | 6 | New Delivery Form |
| 00597042578 | PRADAXA 20 MG PELLET PACK | 0 | 6 | New Delivery Form and Strength |
| 00597043018 | PRADAXA 30 MG PELLET PACK | 0 | 6 | New Delivery Form and Strength |
| 00597043596 | PRADAXA 40 MG PELLET PACK | 0 | 6 | New Delivery Form and Strength |
| 00597044053 | PRADAXA 50 MG PELLET PACK | 0 | 6 | New Delivery Form and Strength |
| 62135025047 | PREDNISOLONE 15 MG/5 ML SOLUTION [Prelone] | 62 | 391 | New Drug |
| 72245064850 | PROLATE 10 MG-300 MG/5 ML SOLUTION | 0 | 4 | New Delivery Form |
| 70954048430 | PYRAZINAMIDE 500 MG TABLET | 62 | 391 | New Drug |
| 68025008830 | RELEXXII ER 45 MG TABLET ER 24 | 0 | 7 | New Strength |
| 68025008930 | RELEXXII ER 63 MG TABLET ER 24 | 0 | 7 | New Strength |
| 71332000501 | REZLIDHIA 150 MG CAPSULE | 62 | 391 | New Drug |
| 16571080901 | SEROQUEL 150 MG TABLET | 54 | 312 | New Manufacturer and Strength |
| 61958150301 | SOVALDI 200 MG TABLET | 18 | 40 | New Delivery Form |
| 69102031901 | SUBVENITE 100 MG TABLET | 60 | 323 | New Drug and Strength |
| 69102015006 | SUBVENITE 150 MG TABLET | 60 | 323 | New Drug and Strength |
| 69102032001 | SUBVENITE 200 MG TABLET | 60 | 323 | New Drug and Strength |
| 69102030101 | SUBVENITE 25 MG TABLET | 60 | 323 | New Drug and Strength |
| 69102030001 | SUBVENITE TABLET START KIT(ORANGE) TABLET DS PK | 14 | 94 | New Drug and Strength |
| 69102031201 | SUBVENITE TABLET START KIT (GREEN) TABLET DS PK | 14 | 94 | New Drug and Strength |
| 69102030601 | SUBVENITE TABLET START KIT (BLUE) TABLET DS PK | 15 | 94 | New Drug and Strength |
| 27437020808 | SUPRAX 400 MG CAPSULE | 4 | 23 | New Delivery Form and Strength |
| 47783064501 | TAKHZYRO 150 MG/ML SYRINGE | 1 | 118 | New Strength |
| 70709006230 | TASCENSO ODT 0.25 MG TABLET RAPDIS | 1 | 65 | New Strength |
| 00480449056 | TASIMELTEON 20 MG CAPSULE [HETLIOZ] | 52 | 328 | New Drug |
| 43547061303 | TEMAZEPAM 22.5 MG CAPSULE [Restoril] | 4 | 80 | New Manufacturer and Strength |
| 43547061110 | TEMAZEPAM 7.5 MG CAPSULE [Restoril] | 18 | 170 | New Manufacturer and Strength |
| 00115261101 | TERBUTALINE SULFATE 2.5 MG TABLET [Brethine] | 47 | 348 | New Strength |
| 31722024730 | TERIFLUNOMIDE 14 MG TABLET [AUBAGIO] | 16 | 224 | New Drug and Strength |
| 31722024630 | TERIFLUNOMIDE 7 MG TABLET [AUBAGIO] | 16 | 224 | New Drug and Strength |
| 69918060160 | TIMOLOL MALEATE 0.5% EYE DROP DROPERETTE [Timoptic Ocumeter] | 4 | 68 | New Manufacturer, Strength and Delivery Form |
| 24208049968 | TIMOPTIC 0.5% OCUDOSE DROP DROPERETTE | 1 | 2 | New Manufacturer, Strength and Delivery Form |
| 00264193310 | TROPHAMINE 10% IV SOLUTION | 54 | 354 | New Drug |
| 00642747101 | TYBLUME 0.1-0.02 MG CHEWABLE TABLET | 16 | 173 | New Drug |
| 81583010005 | ZTALMY 50 MG/ML ORAL SUSPENSION | 62 | 391 | New Drug |
- Ask your prescriber about trying the generic.
- Check for an alternative formulary drug.
- Ask your plan to cover a non-formulary drug.
You will need to work with your doctor or prescriber to explain why you are not able to use the generic medication or why no other formulary drug is acceptable. If your formulary exception is denied, you have the right to appeal your plan’s decision.
- Consider using a Special Enrollment Period and move to another Medicare plan that provides coverage of all your prescription and health needs.
Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the on this site Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at on this site.